Friday, July 10, 2026
🇺🇸 FDA

Intelligence · INN directory

Oncology Drugs Directory

Anticancer agents, immuno-oncology biologics, targeted therapies, and oncology pipeline compounds tracked across FDA, EMA, and congress readouts.

Drugs in segment 40
Companies 1,771
Pipeline programs 20,548

Quick answer

Oncology drugs: NovaPharmaNews indexes 40 pharmaceutical drugs in this therapeutic segment with regulatory status, pipeline programs, patents, and congress coverage cross-links. Anticancer agents, immuno-oncology biologics, targeted therapies, and oncology pipeline compounds tracked across FDA, EMA, and congress readouts.

Recently updated

FDA-approved

40 drugs · Oncology drugs · by data quality · Page 1 of 2

  1. adalimumab-aqvh

    YUSIMRY Coherus Oncology

    INJECTION FDA: approved

  2. denosumab

    CORORA Amgen

    SUBCUTANEOUS FDA: approved · EMA: approved · TGA: approved · PMDA: approved

    M05BX04

  3. exagamglogene autotemcel

    CASGEVY Vertex Pharmaceuticals (Australia) Pty.

    EMA: approved

    B06AX05

  4. adalimumab-aacf

    IDACIO

    SUBCUTANEOUS FDA: approved

  5. adalimumab-aaty

    YUFLYMA

    INJECTION FDA: approved

  6. adalimumab-adaz

    HYRIMOZ

    INJECTION FDA: approved

  7. adalimumab-adbm

    CYLTEZO

    INJECTION FDA: approved

  8. adalimumab-afzb

    ABRILADA

    INJECTION FDA: approved

  9. adalimumab-atto

    AMJEVITA

    INJECTION FDA: approved

  10. adalimumab-bwwd

    HADLIMA

    INJECTION FDA: approved

  11. adalimumab-fkjp

    HULIO

    INJECTION FDA: approved

  12. adalimumab-ryvk

    SIMLANDI

    INJECTION FDA: approved

  13. belimumab

    BENLYSTA

    INJECTION FDA: approved · EMA: approved · PMDA: approved

    L04AG04

  14. certolizumab pegol

    CIMZIA

    INJECTION FDA: approved · EMA: approved · TGA: approved

    L04AB05

  15. dabrafenib mesylate

    TAFINLAR

    ORAL FDA: approved

  16. denosumab-bbdz

    JUBBONTI

    SUBCUTANEOUS FDA: approved

  17. etanercept

    BRENZYS Pfizer Australia Pty Ltd

    SUBCUTANEOUS FDA: approved · EMA: approved · TGA: approved

    L04AB01

  18. etanercept-szzs

    ERELZI

    INJECTION FDA: approved

  19. etanercept-ykro

    ETICOVO

    INJECTION FDA: approved

  20. golimumab

    SIMPONI Janssen-Cilag Pty Ltd

    INJECTION FDA: approved · EMA: approved · TGA: approved

    L04AB06

  21. infliximab-abda

    RENFLEXIS

    INJECTION FDA: approved

  22. infliximab-axxq

    AVSOLA

    INJECTION FDA: approved

  23. infliximab-dyyb

    ZYMFENTRA

    INJECTION FDA: approved

  24. infliximab-qbtx

    IXIFI

    INJECTION FDA: approved

Frequently asked questions

How many oncology drugs are in the directory?

40 drug profiles match this therapeutic area filter based on class, mechanism, target, and INN metadata.

How are drugs assigned to a therapeutic area?

Classification uses WHO therapeutic class, mechanism of action, molecular target, and INN pattern matching against curated oncology, metabolic, CNS, rare disease, and immunology taxonomies.

Where does regulatory data come from?

Profiles combine FDA Drugs@FDA, EMA EPAR references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.